Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-10.24M	-10.69M	-15.41M	-23.43M	-21.27M	-10.07M
Depreciation & Amortization	19.35M	18.82M	21.27M	17.22M	8.72M	9.49M
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-409.53M	16.66M	-5.89M	66.9M	-11.35M	-23.72M
Other Non-Cash Items	401.66M	-17.34M	18.33M	-82.56M	39.49M	21.12M
Deferred Income Tax	6.94M	-290K	-474K	9.2M	-7.41M	-2.26M
Change in Working Capital	-406.88M	745K	-4.31M	67.77M	-18.48M	-8.74M
Operating Cash Flow	14.93M	-6.41M	21.41M	-10.01M	3.54M	11.7M
Capital Expenditures	-6.54M	-3.95M	-13.48M	-12.99M	-13.34M	-11.63M
Cash Acquisitions	n/a	n/a	2.31M	-143.27M	-1.06M	n/a
Purchase of Investments	-68K	-1.88M	-132K	-72K	-56K	-714K
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	3.36M	2.67M	-1.7M	274K	-408K	1.43M
Investing Cash Flow	-3.25M	-3.16M	-13M	-156.05M	-14.86M	-10.91M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-68K	-1.88M	-132K	-72K	-56K	-714K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.65M	-7.24M	-1.17M	180.15M	-2.2M	-5.93M
Financial Cash Flow	-4.65M	-7.24M	-1.17M	180.15M	-2.2M	-5.93M
Net Cash Flow	7.03M	-16.81M	7.24M	14.08M	-13.52M	-5.15M
Free Cash Flow	8.39M	-10.36M	7.93M	-23M	-9.79M	69K